Insiders · VAXX

James Chui

Director at Vaxxinity, Inc. (VAXX)

James Chui has filed 3 insider reports with the SEC since December 2021, as director at Vaxxinity, Inc. (VAXX). James Chui made no open-market purchases or sales in the last 12 months. The latest filing, on June 24, 2022, reports grant or award at Vaxxinity, Inc. (VAXX).

Filings
3
Companies
1
Bought on market
$96K
Sold on market
None

Companies where James Chui is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Vaxxinity, Inc. logo
VAXX
Vaxxinity, Inc.
Director14,000$96K$6.86Jun 24, 2022

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare James Chui with

Questions about James Chui

What is James Chui's role at Vaxxinity, Inc.?
James Chui reports to the SEC as director at Vaxxinity, Inc. (VAXX), according to the latest filing on June 24, 2022.
How many shares does James Chui own?
After the latest filing that states it, James Chui directly owned 14,000 shares of Vaxxinity, Inc. (VAXX). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has James Chui bought or sold stock recently?
The most recent open-market purchase was on December 31, 2021: bought 6,000 shares of Vaxxinity, Inc. (VAXX) for $32.9K at an average of $5.48.
How do I get alerts when James Chui files?
Follow James Chui on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by James Chui (SEC CIK 0001892299). Totals count each trade once, skipping amendments whose original is on file, from Dec 14, 2021 on. View on SEC EDGAR · Get this as JSON